Activin and Inhibin

(S)-ML753286 is a breast cancer resistance protein ( BCRP ) inhibitor with an IC 50 of 0.6 μM on BCRP efflux transporter.In Vivo(S)-ML753286 (Compound A) shows the potency and a potent pharmacokinetic (PK) profile in rats (lower clearance [1.54

(S)-ML753286 is a breast cancer resistance protein ( BCRP ) inhibitor with an IC 50 of 0.6 μM on BCRP efflux transporter.In Vivo(S)-ML753286 (Compound A) shows the potency and a potent pharmacokinetic (PK) profile in rats (lower clearance [1.54

(S)-ML753286 is a breast cancer resistance protein ( BCRP ) inhibitor with an IC 50 of 0.6 μM on BCRP efflux transporter.In Vivo(S)-ML753286 (Compound A) shows the potency and a potent pharmacokinetic (PK) profile in rats (lower clearance [1.54

(S)-Osanetant is the S-enantiomer of Osanetant. Osanetant (SR142801) is a selective NK3 receptor antagonist. Osanetant produces anxiolytic- and antidepressant-like effects and is researched for schizophrenia.Form:Solid.

(S)-PI3Kα-IN-4 is a potent inhibitor of PI3Kα , with an IC 50 of 2.3 nM. (S)-PI3Kα-IN-4 shows 38.3-, 4.25-, and 4.93-fold selectivity for PI3Kα over PI3Kβ , PI3Kδ , and PI3Kγ , respectively. (S)-PI3Kα-IN-4 can be used for the research of cancerIn

(S)-PI3Kα-IN-4 is a potent inhibitor of PI3Kα , with an IC 50 of 2.3 nM. (S)-PI3Kα-IN-4 shows 38.3-, 4.25-, and 4.93-fold selectivity for PI3Kα over PI3Kβ , PI3Kδ , and PI3Kγ , respectively. (S)-PI3Kα-IN-4 can be used for the research of cancerIn

(S)-PI3Kα-IN-4 is a potent inhibitor of PI3Kα , with an IC 50 of 2.3 nM. (S)-PI3Kα-IN-4 shows 38.3-, 4.25-, and 4.93-fold selectivity for PI3Kα over PI3Kβ , PI3Kδ , and PI3Kγ , respectively. (S)-PI3Kα-IN-4 can be used for the research of cancerIn

(S)-PI3Kα-IN-4 is a potent inhibitor of PI3Kα , with an IC 50 of 2.3 nM. (S)-PI3Kα-IN-4 shows 38.3-, 4.25-, and 4.93-fold selectivity for PI3Kα over PI3Kβ , PI3Kδ , and PI3Kγ , respectively. (S)-PI3Kα-IN-4 can be used for the research of cancerIn

(S)-PI3Kα-IN-4 is a potent inhibitor of PI3Kα , with an IC 50 of 2.3 nM. (S)-PI3Kα-IN-4 shows 38.3-, 4.25-, and 4.93-fold selectivity for PI3Kα over PI3Kβ , PI3Kδ , and PI3Kγ , respectively. (S)-PI3Kα-IN-4 can be used for the research of cancerIn

(S)-PI3Kα-IN-4 is a potent inhibitor of PI3Kα , with an IC 50 of 2.3 nM. (S)-PI3Kα-IN-4 shows 38.3-, 4.25-, and 4.93-fold selectivity for PI3Kα over PI3Kβ , PI3Kδ , and PI3Kγ , respectively. (S)-PI3Kα-IN-4 can be used for the research of cancerIn

(S)-Selisistat ((S)-EX-527) is a potent and selective SIRT1 inhibitor, with an IC 50 of 98 nM.In Vitro(S)-Selisistat is an inhibitor of SIRT1 enzymatic activity (IC 50 , 98 nM), identified in a high-throughput screen using bacterially expressed

(S)-Selisistat ((S)-EX-527) is a potent and selective SIRT1 inhibitor, with an IC 50 of 98 nM.In Vitro(S)-Selisistat is an inhibitor of SIRT1 enzymatic activity (IC 50 , 98 nM), identified in a high-throughput screen using bacterially expressed